In this Section |
258841 Comparison of Serum Ferritin and Oxidative Stress Biomarkers between Japanese men with and without Metabolic SyndromeMonday, October 29, 2012
Background: Metabolic syndrome (MS) is closely linked to life-style and is characterized by central obesity leading to pathological conditions such as diabetes mellitus or atherosclerosis. The increased level of oxidative stress, which overwhelms the antioxidative defense capacity, induces oxidative damage to lipids, DNA and proteins. However, the relation between MS and oxidative stress still remains to be investigated in public health for clinical intervention. Methods: Biomarkers of oxidative stress, including urinary 8-hydroxy-2'-deoxyguanosine (8-OHdG), 8-isoprostane, hydrogen peroxide (H2O2), high-sensitivity C-reactive protein (hs-CRP), and serum ferritin were determined in 293 Japanese men with and without MS. Fasting blood and urine samples were collected for determination of above mentioned biomarkers. Blood pressure (BP) and alcohol consumption were also recorded. MS was defined on the basis of the Japanese criterion. Results: Serum ferritin and urinary H2O2 levels were significantly higher in men with MS than those without. There was a significant positive correlation between ferritin and homeostasis model assessment (HOMA-R). In addition, serum ferritin was positively correlated with 8-OHdG and it was negatively correlated with 8-isoprostane and H2O2. By using multiple regression analysis, serum ferritin was closely correlated with HOMA-R, 8-OHdG, and alcohol consumption. Conclusions: Serum ferritin might be a useful marker of MS, reflecting the importance of oxidative stress in Japanese men with MS.
Learning Areas:
Basic medical science applied in public healthClinical medicine applied in public health Learning Objectives: Keywords: Aging, Obesity
Presenting author's disclosure statement:
Qualified on the content I am responsible for because: I have no relationship of a financial, professional, or personal nature exists that would potentially bias the presenter, speaker, discussant, respondent, faculty. I agree to comply with the American Public Health Association Conflict of Interest and Commercial Support Guidelines, and to disclose to the participants any off-label or experimental uses of a commercial product or service discussed in my presentation.
Back to: 3180.0: Special Population and Special Circumstances
|